All In MedTech

FDA Clearance Tracker · P970003-S068

VNS THERAPY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 8, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 8, 2007

Approved

Time to decision

237 days

Received Jun 16, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970003-S068
Device name
VNS THERAPY SYSTEM
Applicant location
Houston, TX
Received
Jun 16, 2006
Decided
Feb 8, 2007
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR USE OF AN ADDITIONAL STERILIZATION METHOD.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.